18
Participants
Start Date
August 7, 2017
Primary Completion Date
December 14, 2017
Study Completion Date
December 14, 2017
Reference capsule GDC-0134
Oral administration of a single dose of 200 milligrams (mg) GDC-0134 reference capsule administered as two 100 mg capsules.
Prototype capsule GDC-0134
Oral administration of a single dose of 200 mg GDC-0134 prototype capsule administered as one 200 mg capsule.
rabeprazole
Oral administration of 20 mg rabeprazole once daily on Days -3, -2 and -1 as well as on Day 1 two hours prior to each administration of GDC-0134 during Period 4.
Quotient Clinical Ltd, Clinical Research Unit, Nottingham
Lead Sponsor
Collaborators (1)
Quotient Clinical
OTHER
Genentech, Inc.
INDUSTRY